Evidence map›Paper›PMID 34147119›Full record

ReviewMicrobial cell factories2021

Genetic tools for the development of recombinant lactic acid bacteria.

Jiapeng Wu, Yongping Xin, Jian Kong, Tingting Guo

Abstract readReview
In one paragraph

Review in Microbial cell factories, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Metabolic engineering ofFood chemistry: X · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Genomic insights and functional evaluation ofFrontiers in microbiology · 2024
    Article
  19. Pivotal role ofFrontiers in medicine · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiapeng WuState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China.
Yongping XinState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China.
Jian KongState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China. kongjian@sdu.edu.cn.
Tingting GuoState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China. guotingting@sdu.edu.cn.ORCID http://orcid.org/0000-0002-2246-6640

Funding

National Key Research and Development Program of China 2019YFA09006700National Natural Science Foundation of Shandong Province ZR2020MC014
6 · The paper itself

Abstract

Lactic acid bacteria (LAB) are a phylogenetically diverse group with the ability to convert soluble carbohydrates into lactic acid. Many LAB have a long history of safe use in fermented foods and are recognized as food-grade microorganisms. LAB are also natural inhabitants of the human intestinal tract and have beneficial effects on health. Considering these properties, LAB have potential applications as biotherapeutic vehicles to delivery cytokines, antigens and other medicinal molecules. In this review, we summarize the development of, and advances in, genome manipulation techniques for engineering LAB and the expected future development of such genetic tools. These methods are crucial for us to maximize the value of LAB. We also discuss applications of the genome-editing tools in enhancing probiotic characteristics and therapeutic functionalities of LAB.

Indexed as

Drug Delivery SystemsBiotechnologyFermented FoodsFood MicrobiologyGene EditingGenetic EnhancementHumansIntestinesLactobacillalesProbioticsFood-grade microorganismsGenome-editing toolsLactic acid bacteriaProbiotic characteristicsTherapeutic functionalities

Identifiers

PMID34147119
PMCPMC8214781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.